Boji Medical TechnologyLtd 관리

관리 기준 확인 4/4

Boji Medical TechnologyLtd CEO는 Tingchun Wang, Jun2011 에 임명되었습니다 의 임기는 13.42 년입니다. 는 CN¥ 1.03B 가치에 해당하는 회사 주식의 31.27% 직접 소유합니다. 1.03B. 경영진과 이사회의 평균 재임 기간은 각각 9.5 년과 4.3 년입니다.

주요 정보

Tingchun Wang

최고 경영자

CN¥414.0k

총 보상

CEO 급여 비율	n/a
CEO 임기	13.4yrs
CEO 소유권	31.3%
경영진 평균 재임 기간	9.5yrs
이사회 평균 재임 기간	4.3yrs

최근 관리 업데이트

Recent updates

We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable

Nov 02

A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb

Oct 08

Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues

May 01

Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce

Mar 06

CEO

Tingchun Wang (59 yo)

13.4yrs

테뉴어

CN¥414,000

보상

Mr. Tingchun Wang, M.D. & Ph D., is a Founder of Boji Medical Technology Co.,Ltd. and has been its General Manager and Chairman since June 11, 2011.Mr. Wang serves as Member of the Board at Guangzhou Funw...

리더십 팀

이름	위치	테뉴어	보상	소유권
Tingchun Wang	Founder	13.4yrs	CN¥414.00k	31.27% CN¥ 1.0b
Xiu Qing Ou	Deputy GM & CFO	13.4yrs	CN¥461.80k	0.099% CN¥ 3.3m
Quan Zhu	Deputy GM & Director	9.5yrs	CN¥1.44m	0.077% CN¥ 2.5m
Bo Tan	Deputy GM & Director	9.5yrs	CN¥937.60k	0.072% CN¥ 2.4m
Yu Ping Han	Deputy General Manager	no data	CN¥865.90k	0.072% CN¥ 2.4m
Shaobo Wen	Deputy General Manager	3.6yrs	CN¥1.27m	0.019% CN¥ 615.4k
Lian Zuo	Deputy General Manager	2.9yrs	CN¥1.20m	0.011% CN¥ 365.1k
Zhanpeng Chen	Accounting Supervisor	no data	데이터 없음	데이터 없음

9.5yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 관리: 300404 의 관리팀은 노련하고 경험 (평균 재직 기간 9.5 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Tingchun Wang	Founder	13.4yrs	CN¥414.00k	31.27% CN¥ 1.0b
Quan Zhu	Deputy GM & Director	9.5yrs	CN¥1.44m	0.077% CN¥ 2.5m
Bo Tan	Deputy GM & Director	9.5yrs	CN¥937.60k	0.072% CN¥ 2.4m
Kejian Zhang	Director	4.3yrs	CN¥84.00k	데이터 없음
Qing Chen	Independent Director	4.3yrs	CN¥84.00k	데이터 없음
Wang Fang	Supervisor	4.3yrs	데이터 없음	데이터 없음
Kang Xie	Independent Director	2.5yrs	CN¥84.00k	데이터 없음
Huayi Li	Independent Director	1.3yrs	CN¥35.00k	데이터 없음
Peidan Xian	Non-Employee Supervisor	1.3yrs	데이터 없음	데이터 없음

4.3yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 이사회: 300404 의 이사회는 경험(평균 재직 기간 4.3 년)으로 간주됩니다.

Boji Medical TechnologyLtd 관리

관리 기준 확인 4/4

주요 정보

최근 관리 업데이트

Boji Medical Technology Co.,Ltd., Annual General Meeting, May 16, 2024

High number of new directors

Boji Medical Technology Co., Ltd. Approves the Election of Directors and Non-Employee Supervisors

Less than half of directors are independent

Insufficient new directors

Recent updates

We Don’t Think Boji Medical TechnologyLtd's (SZSE:300404) Earnings Should Make Shareholders Too Comfortable

Third quarter 2024 earnings released: EPS: CN¥0.034 (vs CN¥0.015 in 3Q 2023)

A Piece Of The Puzzle Missing From Boji Medical Technology Co.,Ltd.'s (SZSE:300404) 39% Share Price Climb

Boji Medical Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Second quarter 2024 earnings released: EPS: CN¥0.036 (vs CN¥0.016 in 2Q 2023)

Boji Medical Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 27, 2024

New minor risk - Profit margin trend

Boji Medical TechnologyLtd's (SZSE:300404) Profits Appear To Have Quality Issues

Boji Medical Technology Co., Ltd. Announces Profit Distribution Proposal for 2023

Boji Medical Technology Co.,Ltd., Annual General Meeting, May 16, 2024

First quarter 2024 earnings released: EPS: CN¥0.043 (vs CN¥0.032 in 1Q 2023)

Boji Medical Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Further Upside For Boji Medical Technology Co.,Ltd. (SZSE:300404) Shares Could Introduce Price Risks After 35% Bounce

New minor risk - Share price stability

Boji Medical Technology Co., Ltd. (SZSE:300404) announces an Equity Buyback for CNY 20 million worth of its shares.

Investor sentiment deteriorates as stock falls 25%

Boji Medical Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

New minor risk - Shareholder dilution

Third quarter 2023 earnings released: EPS: CN¥0.015 (vs CN¥0.018 in 3Q 2022)

Boji Medical Technology Co., Ltd. to Report Q3, 2023 Results on Oct 27, 2023

High number of new directors

Second quarter 2023 earnings released: EPS: CN¥0.016 (vs CN¥0.007 in 2Q 2022)

Boji Medical Technology Co., Ltd. Approves the Election of Directors and Non-Employee Supervisors

Boji Medical Technology Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 11 July 2023

First quarter 2023 earnings released: EPS: CN¥0.032 (vs CN¥0.034 in 1Q 2022)

Boji Medical Technology Co., Ltd. announced a financing transaction

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.018 (vs CN¥0.052 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.007 (vs CN¥0.021 in 2Q 2021)

Boji Medical Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 02 June 2022

Boji CRO Approves Cash Dividend for the Year 2021

Boji Medical Technology Co., Ltd. Proposes Final Cash Dividend for 2021

First quarter 2022 earnings released: EPS: CN¥0.048 (vs CN¥0.033 in 1Q 2021)

Insufficient new directors

Third quarter 2021 earnings released: EPS CN¥0.074 (vs CN¥0.034 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.03 (vs CN¥0.078 in 2Q 2020)

Guangzhou Boji Medical & Biotechnological Co., Ltd. Approves Cash Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.033 (vs CN¥0.026 loss in 1Q 2020)

New 90-day low: CN¥10.50

New 90-day low: CN¥12.13

Third quarter earnings released

Guangzhou Boji Medical & Biotechnological Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020

New 90-day low: CN¥12.61

First half earnings released

New 90-day low - CN¥14.19

Guangzhou Boji Medical & Biotechnological Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥17.57

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령